
Leg Ulcer Treatments Market Report 2026
Global Outlook – By Ulcer Type (Venous Leg Ulcers, Arterial Leg Ulcers, Diabetic Leg Ulcers, Pressure Ulcers, Other Ulcer Types), By Treatment Type (Advanced Wound Care Therapy, Traditional Wound Care, Surgical Treatment, Adjunctive Therapy), By End User (Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Leg Ulcer Treatments Market Overview
• Leg Ulcer Treatments market size has reached to $4.05 billion in 2025 • Expected to grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Prevalence Of Chronic Wounds Driving Market Growth Due To Increasing Geriatric Population • Market Trend: Portable Negative Pressure Therapy System Enhances Home-Based Chronic Wound Care And Patient Mobility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Leg Ulcer Treatments Market?
Leg ulcer treatments refer to the range of medical therapies, procedures, and wound-care solutions used to manage and heal chronic wounds on the lower limbs, typically caused by venous insufficiency, arterial disease, diabetes, or pressure-related conditions. These treatments focus on promoting wound healing, preventing infection, reducing pain, and improving circulation through clinical intervention, specialized dressings, compression therapy, and advanced wound-care techniques. The main ulcer types of leg ulcer treatments include venous leg ulcers, arterial leg ulcers, diabetic leg ulcers, pressure ulcers, and other ulcer types. Venous leg ulcers refer to chronic wounds that develop due to impaired venous circulation, typically occurring on the lower legs. These conditions are managed through treatment types including advanced wound care therapy, traditional wound care, surgical treatment, and adjunctive therapy and they are utilized by end users including hospitals and clinics, homecare settings, ambulatory surgical centers, and others.
What Is The Leg Ulcer Treatments Market Size and Share 2026?
The leg ulcer treatments market size has grown strongly in recent years. It will grow from $4.05 billion in 2025 to $4.36 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing diabetes prevalence, rising peripheral vascular disease cases, limited access to advanced wound care, growing hospital admissions for chronic wounds, low awareness of early ulcer management.What Is The Leg Ulcer Treatments Market Growth Forecast?
The leg ulcer treatments market size is expected to see strong growth in the next few years. It will grow to $5.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to expanding geriatric population burden, rising demand for outpatient wound care services, increasing focus on preventive vascular screening, growth in home based wound management adoption, improving clinical guidelines for chronic ulcer treatment. Major trends in the forecast period include rising prevalence of chronic venous and diabetic ulcers, increasing geriatric population with impaired wound healing, growing incidence of diabetes related complications leading to leg ulcers, shift toward evidence based standardized wound care protocols, increasing adoption of compression and debridement based clinical practices.Global Leg Ulcer Treatments Market Segmentation
1) By Ulcer Type: Venous Leg Ulcers, Arterial Leg Ulcers, Diabetic Leg Ulcers, Pressure Ulcers, Other Ulcer Types 2) By Treatment Type: Advanced Wound Care Therapy, Traditional Wound Care, Surgical Treatment, Adjunctive Therapy 3) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Venous Leg Ulcers: Active Venous Leg Ulcers, Recurrent Venous Leg Ulcers, Chronic Venous Leg Ulcers, Infected Venous Leg Ulcers, Non Infected Venous Leg Ulcers 2) By Arterial Leg Ulcers: Ischemic Arterial Ulcers, Necrotic Arterial Ulcers, Painful Arterial Ulcers, Non Healing Arterial Ulcers, Mixed Arterial Ulcers 3) By Diabetic Leg Ulcers: Neuropathic Diabetic Ulcers, Ischemic Diabetic Ulcers, Neuro Ischemic Diabetic Ulcers, Infected Diabetic Ulcers, Non Infected Diabetic Ulcers 4) By Pressure Ulcers: Stage One Pressure Ulcers, Stage Two Pressure Ulcers, Stage Three Pressure Ulcers, Stage Four Pressure Ulcers, Unstageable Pressure Ulcers 5) By Other Ulcer Types: Traumatic Ulcers, Vasculitic Ulcers, Malignant Ulcers, Infectious Ulcers, Mixed Etiology UlcersWhat Is The Driver Of The Leg Ulcer Treatments Market?
The rising prevalence of chronic wounds is expected to propel the growth of the leg ulcer treatments market going forward. Chronic wounds are injuries that fail to heal within the expected timeframe, typically remaining open for more than three months. The prevalence of chronic wounds is rising due to an aging population, as older adults are more susceptible to conditions that slow healing, such as diabetes, poor circulation, and weakened skin. Leg ulcer treatments help to manage chronic wounds by improving blood circulation, preventing and controlling infection, reducing inflammation, and supporting tissue repair through compression therapy, specialized dressings, and targeted medical care that together promote steady and effective healing. For instance, in November 2023, according to the National Health Service (NHS) England, a UK-based government department, between 01/10/2022 and 01/10/2023, a total of 193 inpatients were reported to have developed bed sores, pressure sores, or pressure ulcers during their hospital stay. Therefore, the rising prevalence of chronic wounds is driving the growth of the leg ulcer treatments industry.Key Players In The Global Leg Ulcer Treatments Market
Major companies operating in the leg ulcer treatments market are Cardinal Health Inc., Essity AB, Solventum Corporation, B. Braun Melsungen AG, Smith & Nephew plc, ConvaTec Group Plc, Mölnlycke Health Care AB, Coloplast A/S, Paul Hartmann AG, Winner Medical Co. Ltd., Integra LifeSciences Holdings Corporation, Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical SAS, Organogenesis Holdings Inc., MiMedX Group Inc., DeRoyal Industries Inc., Advancis Medical Limited, MediWound Ltd., Triage Meditech Pvt. Ltd., Natrox Wound Care Ltd.Global Leg Ulcer Treatments Market Trends and Insights
Major companies operating in the leg ulcer treatments market are focusing on developing innovative products, such as portable negative pressure wound therapy (NPWT) systems to improve healing outcomes, enhance patient mobility, and reduce long-term treatment costs associated with chronic venous and diabetic leg ulcers. NPWT systems are advanced wound-care devices that apply controlled, localized sub-atmospheric pressure to the wound bed using a sealed dressing connected to a compact pump and drainage canister. For instance, in April 2024, Smith+Nephew plc, a UK-based medical technology company, launched the RENASYS EDGE Negative Pressure Wound Therapy System, an innovative home-care-focused device designed to support patients living with chronic wounds, including leg ulcers. The system is lightweight and compact, allowing it to be easily carried or worn by patients, and features a discreet canister that minimizes visibility while maintaining effective exudate management. It operates quietly to avoid disrupting daily activities, improving patient compliance and quality of life during long-term treatment. The device is widely used for managing chronic venous leg ulcers, diabetic foot ulcers, and other complex wounds, offering improved mobility, comfort, and healing efficiency compared to conventional dressing-based approaches.What Are Latest Mergers And Acquisitions In The Leg Ulcer Treatments Market?
In August 2023, Coloplast A/S, a Denmark-based healthcare company, acquired Kerecis for an undisclosed amount. With this acquisition, Coloplast A/S aimed to strengthen its position in advanced wound care by adding fish-skin-based biologic graft technology to its portfolio, thereby expanding its regenerative medicine and tissue repair capabilities in chronic wound and surgical care markets. Kerecis is an Iceland-based medical device and biologics company that specializes in developing fish-skin graft products used for wound healing, tissue regeneration, and soft tissue repair in chronic and acute wounds.Regional Outlook
North America was the largest region in the leg ulcer treatments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Leg Ulcer Treatments Market?
The leg ulcer treatments market consists of revenues earned by entities by providing services such as wound assessment, debridement procedures, compression therapy application, infection management, outpatient wound care services, home-based wound management, and chronic wound monitoring and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The leg ulcer treatments market also includes sales of advanced wound dressings, compression bandages, wound care devices, negative pressure wound therapy systems, topical treatment products, and related medical supplies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Leg Ulcer Treatments Market Report 2026?
The leg ulcer treatments market research report is one of a series of new reports from The Business Research Company that provides leg ulcer treatments market statistics, including leg ulcer treatments industry global market size, regional shares, competitors with a leg ulcer treatments market share, detailed leg ulcer treatments market segments, market trends and opportunities, and any further data you may need to thrive in the leg ulcer treatments industry. This leg ulcer treatments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Leg Ulcer Treatments Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $4.36 billion |
| Revenue Forecast In 2030 | $5.9 billion |
| Growth Rate | CAGR of 7.8% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Ulcer Type, Treatment Type, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the leg ulcer treatments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Cardinal Health Inc., Essity AB, Solventum Corporation, B. Braun Melsungen AG, Smith & Nephew plc, ConvaTec Group Plc, Mölnlycke Health Care AB, Coloplast A/S, Paul Hartmann AG, Winner Medical Co. Ltd., Integra LifeSciences Holdings Corporation, Lohmann & Rauscher International GmbH & Co. KG, Urgo Medical SAS, Organogenesis Holdings Inc., MiMedX Group Inc., DeRoyal Industries Inc., Advancis Medical Limited, MediWound Ltd., Triage Meditech Pvt. Ltd., Natrox Wound Care Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
